NGS lung cancer panel was negative for mutations in ALK, ATK1, BRAF, CDK4, CTNNB1, DDR2, EGFR, FGFR2, FGFR3, HER2, HER3, HER4, JAK2, JAK3, KRAS, MAP2K1, MET, NRAS, PIK3CA, ROS1, and rearrangements in ALK, BRAF, FGFR3, NTRK, RET, and ROS1. Here, ROS1 is linked to lung cancer.